MSTN and muscle atrophy: Indeed, flavonoids have been proposed as potential candidates to treat muscle atrophy due to their role in improving mitochondrial function [72] and decreasing proteolysis through the downregulation of myostatin [73] and the atrogenes MURF-1 and atrogin-1 [74].